Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oncotarget ; 9(88): 35830-35843, 2018 Nov 09.
Article in English | MEDLINE | ID: mdl-30533198

ABSTRACT

Phosphorylation of p62/SQSTM1 (p62) on Serine 349 (P-Ser349 p62) as well as proteasome dysfunction have been shown to activate the cell protective Keap1/Nrf2 pathway. We showed previously that BAY 11-7085-induced human synovial fibroblast cell death includes autophagy and p62 downregulation. In this work, we have studied expression of P-Ser349 p62 in human synovial fibroblasts. Results showed that P-Ser349 p62 was not detected in synovial cell extracts unless cells were cultured in the presence of proteasome inhibitor (MG132). MG132 revealed P-Ser349 p62 turnover, that was further increased by concomitant autophagy inhibition and markedly enhanced in serum starved cells. Starvation sensitized synovial fibroblasts to BAY 11-7085 while MG132 protected both non-starved and starved cells from BAY 11-7085-induced cell death. Lentivirus mediated overexpression of phosphorylation-mimetic p62 mutant S349E markedly protected synovial fibroblasts from BAY 11-7085. Inhibitor of Keap1-P-S349 p62 interaction, K67, had synergistic effect with MG132. Starvation increased p62 molecular weight, that was reversed by serum and bovine serum albumin re-feeding. Furthermore, starvation markedly induced RAD23B. Increased endo-ß-N-acetylglucosaminidase (ENGase) turnover was detected in starved synovial fibroblasts. PNGase F treatment produced faster migration p62 form in human synovial tissue extracts but starvation-like p62 form of higher molecular weight in synovial cell extracts. Co-transfection of NGLY1, with p62 or p62 mutants S349A and S349E markedly stabilized p62 expressions in HEK293 cells. Tunicamycin upregulated p62 and protected synovial fibroblasts from BAY 11-7085-induced cell death. These results showed that P-Ser349 p62 has pro-survival role in human synovial fibroblasts and that de-glycosylation events are involved in p62 turnover.

2.
Clin Chim Acta ; 431: 60-5, 2014 Apr 20.
Article in English | MEDLINE | ID: mdl-24508999

ABSTRACT

INTRODUCTION: Standardization of immunoassays for 25(OH)-vitamin D determination is a major problem in clinical practice. A worldwide standardization program has started to address this and will reduce the bias observed between immunoassays. We aimed to calibrate 5 immunoassays on a LC-MS/MS traceable to the SRM 2972 and the ID-LC-MS/MS 25(OH)D Reference Method Procedure to see if the re-standardization would be efficient in a population of 3rd trimester pregnant women (PW), hemodialysis (HD) and osteoporosis (OP) patient. MATERIAL AND METHODS: 184 serum samples (25(OH)D: 8.4-87 ng/ml) were selected to calibrate the immunoassays (Abbott-Architect, Roche-Elecsys, DiaSorin-Liaison, Siemens-Centaur and IDS-iSYS). Chromsystems MassChrom method was used as the referenced. Serum obtained in 34 PW, 25 HD and 34 OP patients were used as comparatives. RESULTS: After adjusting to LC-MS/MS, immunoassays had regression slopes nearly identical to 1.0 with intercepts <0.5 ng/ml. However, in special populations, a systematic bias was still observed, except for iSYS. CONCLUSIONS: Re-standardization of 25(OH)D immunoassay will globally improve the differences. However, patients with a different serum matrix will still present significantly different results when they will be run with different methods. For those patients, the LC-MS/MS method seems to be the method of choice, even if some immunoassays are less influenced than others.


Subject(s)
Hydroxycholecalciferols/blood , Adult , Automation , Calibration , Chromatography, High Pressure Liquid , Female , Humans , Immunoassay/methods , Mass Spectrometry , Osteoporosis/blood , Pregnancy , Reference Standards , Renal Dialysis , Reproducibility of Results , Vitamin D-Binding Protein/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...